Penumbra, Inc. (NYSE: PEN) announced additional results of the ground-breaking STORM-PE randomized controlled trial (RCT), ...
Physical therapy is routinely recommended for knee pain attributed to a degenerative meniscal tear, but its efficacy has not ...
The once-daily oral drug, a SARS-CoV-2 main protease inhibitor developed by Shionogi, is registered in Japan and Singapore ...
The 37th Annual Transcatheter Cardiovascular Therapeutics (TCT2025) symposium was held grandly in San Francisco, USA, attracting widespread attention from the global cardiovascular community. On the ...
The results are likely to be more relevant to patients in sub-Saharan Africa than to those in high-resource settings, the ...
ScienceAlert on MSN
One Dietary Supplement Was Shown to Reduce Aggression by Up to 28%
Across all the trials, a modest but noticeable short-term effect was found, translating to up to a 28 percent reduction in ...
Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O6-Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET) The median time post-HCT was ...
A collaborative effort across 14 clinical centers in Canada and Australia reports that pregnant women with type 1 diabetes ...
Every week of 2025 seems to bring a new health headline, whether it's about climbing autism rates, changing vaccination ...
Automated insulin delivery (AID) systems have been shown to be beneficial for patients with type 1 diabetes, but data are needed from randomized, controlled trials regarding their role in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback